- Acute and chronic effects of viral diseases often involve immune-mediated responses, including inflammation, immune activation, and autoimmunity. Therapeutic interventions must often target both ends of the virus-immune system spectrum.
- Statins reduce severe cardiovascular events in people with HIV, even in individuals with low baseline cardiovascular risk.
- Long-COVID immunopathogenesis is complex but its understanding is advancing rapidly. The consequences of immune-mediated damage in long COVID share similarities (and differences) with other post-viral diseases like Ebola and MF/CFS
- Viruses can also trigger autoimmunity. Epstein-Barr Virus is tightly linked with the onset of Multiple Sclerosis through several autoimmune mechanisms. Viral encephalitis also often has an autoimmune background
- Immune therapies targeting the inflammasome or virus-specific CAR-T cells, among others, are advancing towards the cure of different acute and chronic viral diseases

Meeting category
Date(s)
6 Sep 2023 - 7 Sep 2023
Program Language
English
Location
Rockville,
MD,
United States
Meeting type
Hybrid Meeting

Viral Infections & Inflammation Workshop 2023
Related Enduring Materials
Enduring Materials
5 Key Messages from VII Workshop 2022
Program
Day 1, Wednesday 6 September
Opening of the Workshop -
Plenary Talk: Update on the REPRIEVE Trial to Prevent Cardiovascular Events in People with HIV
Session 1: Post-COVID Syndromes -
Viruses, Immune Dysfunction, and ME/CFS
Underlying Mechanisms of Long COVID
Satellite Symposium -
The Impact of Viral Glycoproteins on Inflammation and Immunity
Session 2: Post-infectious Syndromes -
Immune Signatures in Vaccine-Associated Myocarditis
What We Know Now about HIV and Long COVID
Epstein–Barr Virus and Multiple Sclerosis: Which Mechanisms are at Play?
(O_#3) A Role for Inflammasome Activation and Oxidative Stress in Sars-CoV-2 Breakthrough Infection and Symptomatic Rebound
Silvia Lucena Lage
NIH, United States
Day 2, Thursday 7 September
Session 3: Post-acute Sequelae Following Different Infections -
Post-acute Sequelae following Ebola infection
Endogeneous Retroviruses and Inflammation
Session 4: Chronic Viral Infections and Inflammation-related Comorbidities -
HIV, Inflammation, and Macrophages
Inflammation in People with Low Nadir CD4 Counts
Acute Disseminated Encephalomyelitis
Session 5: Interventions Targeting Inflammation and Post-viral Syndromes -
Inflammasome Activation in Severe Cases of COVID-19
Developing CAR T Cells for Use in Chronic HIV Infection
(O_#7) Impact of Glatiramer Acetate Treatment in SIVmac-Infected Macaques
Beatrice Jacqulin
Institut Pasteur, France
Overview
Symposium
Committees
Support
Endorsers
Media
Previous Editions